Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sara Pellegrino - Senior Vice President, Investor & Public Relations & Corporate Communications Fred Vogt - Interim President & Chief Executive Officer Igor Bilinsky - Chief Operating Officer Jim Ziegler - Executive Vice President, Commercial Friedrich Finckenstein - Chief Medical Officer Jean-Marc Bellemin - Chief Financial Officer Conference Call Participants Peter Lawson - Barclays ...